Zai Lab Executive Plans to Sell $96,600 in Stock Following Recent Transactions
Zai Lab executive Yajing Chen filed Form 144 indicating intent to sell 2,675 American Depositary Shares with an aggregate market value of $96,651.76.
Rhea-AI Filing Summary
Zai Lab executive Yajing Chen filed Form 144 indicating intent to sell 2,675 American Depositary Shares with an aggregate market value of $96,651.76. The sale is scheduled for June 26, 2025, through Fidelity Brokerage Services on NASDAQ.
The shares were acquired on June 25, 2025, through restricted stock vesting as part of compensation. The filing notes that the sale is partially intended to cover tax obligations from the vested equity award distribution.
Previous trading activity by Chen in the past 3 months includes:
- June 2, 2025: Sold 9,618 shares for $288,540.00
- April 4, 2025: Sold 924 shares for $30,592.25
- April 2, 2025: Sold 5,280 shares for $189,521.38
The company has approximately 486.85 million shares outstanding. The filing was signed by Wade Moss as a representative of Fidelity Brokerage Services, acting as attorney-in-fact for Chen.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the reason for ZLAB Officer Chen Yajing's planned stock sale in June 2025?
AI-generated analysis. How Rhea-AI works. Not financial advice.